Dipeptidyl peptidase‐4 inhibitors as preferable oral hypoglycemic agents in terms of treatment satisfaction: Results from a multicenter, 12‐week, open label, randomized controlled...

por Ishii, Hitoshi, Hayashino, Yasuaki, Akai, Yasuhiro, Yabuta, Matahiro, Tsujii, Satoru
Publicado 2017